Join us for our upcoming webinar:
Igenomix: Product of Conception Testing
Thursday – January 27th, 2022
Time: 12:00PM EST / 9:00AM PT
LABORATORY & SCIENTIFIC ADVISOR
Endometrial microbiota composition is associated with reproductive outcome in infertile patients
New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatment strategies.Learn more!
Vitrolife completes THE acquisition of Igenomix
Together, we create a global leader in reproductive health
It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.Visit Vitrolife website
At Igenomix, we support research, science, innovation, and the future of IVF technology.
In 2021 Igenomix published 41 Scientific Publications